<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00601354</url>
  </required_header>
  <id_info>
    <org_study_id>K23MH066330</org_study_id>
    <secondary_id>K23MH066330</secondary_id>
    <nct_id>NCT00601354</nct_id>
  </id_info>
  <brief_title>Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder</brief_title>
  <official_title>Comparing Orlistat/Alli to Orlistat/Alli Plus Guided Self-help Group Therapy in Overweight Binge Eaters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effectiveness of adding guided self-help group therapy to a
      weight loss program in achieving weight loss and reducing binge eating in overweight binge
      eaters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Binge eating disorder is one of the most common eating disorders, with more than 4 million
      Americans affected. Following a binge eating episode, in which a person eats an excessive
      amount of food in a short period of time, the person often experiences feelings of guilt,
      depression, embarrassment, and disgust. Beyond the emotional distress caused by binge eating,
      people who binge eat are at a higher risk for more serious health problems associated with
      weight gain. These health problems may include high blood pressure, diabetes, heart disease,
      high cholesterol, and certain types of cancer. Thus, seeking effective treatment for binge
      eating disorder is vital to an affected person's overall physical and mental well-being.
      Managed weight loss programs, combined with certain forms of psychotherapy, have shown
      success in providing the direction and proper motivation to eat healthily and to prevent
      future binge eating episodes. This study will evaluate the effectiveness of adding guided
      self-help group therapy to the alli weight loss program in achieving weight loss and reducing
      binge eating in overweight binge eaters.

      Participation in this single-blind study will last 36 weeks. Initial assessments will be
      divided over two 1- to 2-hour sessions. These assessments will include a history of any
      medical illness, height and weight measurements, and an eating disorder evaluation.
      Participants will also answer several questionnaires about self-esteem, feelings of
      depression, and emotion and eating. Participants will then be randomly assigned to one of two
      treatment groups: the alli program with the use of the weight loss drug orlistat or the alli
      program with the use of orlistat plus guided self-help group psychotherapy. All participants
      will take the over-the-counter weight loss medication orlistat three times a day for 12 weeks
      in conjunction with the alli program, a comprehensive weight loss program with online access.
      Participants assigned to the psychotherapy group will also attend 12 weekly guided self-help
      group psychotherapy sessions. These sessions will include behavioral support for adapting to
      the lifestyle changes promoted by the alli weight loss program.

      All participants will undergo 12 weeks of active participation, 18 weeks of maintenance, and
      18 weeks of follow-up. At various intervals during the first 6 months of the study,
      participants will answer a short group of questions concerning current binge eating habits;
      adherence to prescribed food, activity, and medication plan; and emotional state. The initial
      assessments will be repeated at Weeks 12, 30, and 42.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight Loss</measure>
    <time_frame>3 months: Measured from pre to post treatment</time_frame>
    <description>Change in weight in lbs from per to post treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Binge Frequency</measure>
    <time_frame>3 months: Measured from pre to post treatment</time_frame>
    <description>frequency of objective binge days over prior 28 days</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Weeks of Adherence to Orlistat</measure>
    <time_frame>Number of adherent weeks over 1 year study</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Overweight</condition>
  <condition>Eating Disorders</condition>
  <arm_group>
    <arm_group_label>Emotion Regulation Group therapy + alli</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program, plus 12 weekly sessions of guided self-help group psychotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Orlistat/alli program meds only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Emotion regulation group therapy</intervention_name>
    <description>Emotion regulation guided self-help group therapy involves twelve 2-hour sessions of guided self-help group psychotherapy.</description>
    <arm_group_label>Emotion Regulation Group therapy + alli</arm_group_label>
    <other_name>emotion regulation guided self-help group therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Orlistat/alli program</intervention_name>
    <description>The orlistat/alli program involves taking 60 mg orlistat three times a day and participating in the alli program, a comprehensive behavioral weight loss program with online access.</description>
    <arm_group_label>Emotion Regulation Group therapy + alli</arm_group_label>
    <arm_group_label>Orlistat/alli program meds only</arm_group_label>
    <other_name>Alli</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index greater than 27

          -  Binge eating at least two times per week during the 6 months prior to study entry

        Exclusion Criteria:

          -  Current psychosis

          -  Current suicidal ideations

          -  Pregnant

          -  Receiving concurrent psychotherapy

          -  Unstable on psychotropic medications for 3 months prior to study entry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Debra L. Safer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University Department of Psychiatry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2008</study_first_submitted>
  <study_first_submitted_qc>January 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2008</study_first_posted>
  <results_first_submitted>June 18, 2013</results_first_submitted>
  <results_first_submitted_qc>June 26, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 9, 2013</results_first_posted>
  <last_update_submitted>June 26, 2013</last_update_submitted>
  <last_update_submitted_qc>June 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Debra L. Safer</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Binge Eating</keyword>
  <keyword>Orlistat</keyword>
  <keyword>Alli</keyword>
  <keyword>Guided Self-Help</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Binge-Eating Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Orlistat</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited through newspaper advertisements and flyers. The study took place at an outpatient psychiatry department of a large university medical center.</recruitment_details>
      <pre_assignment_details>There was no wash out, run-in, or transition following participant enrollment.Exclusion criteria are described previously. Main exclusion was weight less than 27 kg/m2.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>OTC Orlistat + Guided Self-help Affect Regulation</title>
          <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program, plus 12 weekly sessions of guided self-help group psychotherapy</description>
        </group>
        <group group_id="P2">
          <title>OTC Orlistat /Medication Management Alone</title>
          <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program alone</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>OTC Orlistat + Guided Self-help Affect Regulation</title>
          <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program, plus 12 weekly sessions of guided self-help group psychotherapy</description>
        </group>
        <group group_id="B2">
          <title>OTC Orlistat /Medication Management Alone</title>
          <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program alone</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.6" spread="11.2"/>
                    <measurement group_id="B2" value="50.1" spread="4.1"/>
                    <measurement group_id="B3" value="49.4" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Weight Loss</title>
        <description>Change in weight in lbs from per to post treatment</description>
        <time_frame>3 months: Measured from pre to post treatment</time_frame>
        <population>Used intent-to-treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>OTC Orlistat + Guided Self-help Affect Regulation</title>
            <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program, plus 12 weekly sessions of guided self-help group psychotherapy</description>
          </group>
          <group group_id="O2">
            <title>OTC Orlistat /Medication Management Alone</title>
            <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program alone</description>
          </group>
        </group_list>
        <measure>
          <title>Weight Loss</title>
          <description>Change in weight in lbs from per to post treatment</description>
          <population>Used intent-to-treat analysis</population>
          <units>lbs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.15" spread="14.36"/>
                    <measurement group_id="O2" value="3.61" spread="8.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binge Frequency</title>
        <description>frequency of objective binge days over prior 28 days</description>
        <time_frame>3 months: Measured from pre to post treatment</time_frame>
        <population>Intent to treat</population>
        <group_list>
          <group group_id="O1">
            <title>OTC Orlistat + Guided Self-help Affect Regulation</title>
            <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program, plus 12 weekly sessions of guided self-help group psychotherapy</description>
          </group>
          <group group_id="O2">
            <title>OTC Orlistat /Medication Management Alone</title>
            <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program alone</description>
          </group>
        </group_list>
        <measure>
          <title>Binge Frequency</title>
          <description>frequency of objective binge days over prior 28 days</description>
          <population>Intent to treat</population>
          <units>% change objective binge days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.0" spread="2.13"/>
                    <measurement group_id="O2" value="12.11" spread="5.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Weeks of Adherence to Orlistat</title>
        <time_frame>Number of adherent weeks over 1 year study</time_frame>
        <population>Intent to treat</population>
        <group_list>
          <group group_id="O1">
            <title>OTC Orlistat + Guided Self-help Affect Regulation</title>
            <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program, plus 12 weekly sessions of guided self-help group psychotherapy</description>
          </group>
          <group group_id="O2">
            <title>OTC Orlistat /Medication Management Alone</title>
            <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program alone</description>
          </group>
        </group_list>
        <measure>
          <title>Weeks of Adherence to Orlistat</title>
          <population>Intent to treat</population>
          <units>week of adherence to orlistat</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" spread="17.3"/>
                    <measurement group_id="O2" value="20.6" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>OTC Orlistat + Guided Self-help Affect Regulation</title>
          <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program, plus 12 weekly sessions of guided self-help group psychotherapy</description>
        </group>
        <group group_id="E2">
          <title>OTC Orlistat /Medication Management Alone</title>
          <description>Group taking the weight loss medication orlistat (alli), in conjunction with the alli weight loss program alone</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Debra L Safer</name_or_title>
      <organization>Stanford University</organization>
      <phone>650-723-7928</phone>
      <email>dlsafer@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

